Hua Dong

Title: Innovations of Hua Dong in Milbemycin Production

Introduction

Hua Dong is a notable inventor based in Hubei, China. He has made significant contributions to the field of pharmaceutical production, particularly in the development of high-yield strains for milbemycin. His innovative approach has led to advancements that benefit both the industry and market demands.

Latest Patents

Hua Dong holds a patent for a milbemycin strain with high-yield and its application. The patent describes a strain for high-yield production of milbemycin, specifically detailing the original strain MI-W1-2017001, which underwent mutation breeding using an atmospheric and room temperature plasma mutation method. This process resulted in the creation of a high-yield strain, HZMRYB-5. The fermentation level of this new strain is improved by approximately 70% compared to the original strain. Furthermore, through optimization of the fermentation process and formulation, the fermentation level is enhanced by an additional 35%. This innovation significantly reduces the fermentation cost of the product while meeting industrial fermentation level requirements. The optimized fermentation process achieves a nearly 3:7 ratio of A3 and A4 in the fermentation liquid through mixed fermentation of strains MI-W1-2017001 and HZMRYB-5, effectively addressing market demands and streamlining the process steps of separation, purification, and mixing.

Career Highlights

Hua Dong is currently associated with Hubei Honch Pharmaceutical Co., Ltd. His work at this company has been pivotal in advancing the production techniques for milbemycin, showcasing his expertise in the field. His innovative contributions have positioned him as a key figure in pharmaceutical research and development.

Collaborations

Hua Dong collaborates with notable colleagues, including Renwen Zhang and Wenkai Zhang. Their teamwork has fostered an environment of innovation and progress within their projects.

Conclusion

Hua Dong's contributions to the field of milbemycin production through his innovative patent demonstrate his commitment to advancing pharmaceutical technologies. His work not only enhances production efficiency but also meets the growing demands of the market.